We frequently refer to dementia and Alzheimer’s as if they are the same thing, they are not. Alzheimer’s is one of 25 distinct conditions that cause dementia, truem it is the most common cause. Other major conditions include vascular dementia, frontotemporal dementia and Lewy body dementia. Multiple conditions can simultaneously affect the brain, resulting in mixed dementia, a condition that is also prevalent.
Alzheimer’s is a growing, and very serious condition.
- As of January 1, 2025, we estimate that 771,939 people in Canada are living with dementia.
- Every day, more than 414 people in Canada develop dementia. This is more than 17 every hour.
The numbers are for Canada, please refer to your jurisdiction for reporting, and numbers.
In this book, we examine the nature of Alzheimer’s disease and dementia, its relationship to Type 2 Diabetes, and the fact that Alzheimer’s is now referred to as Type 3 Diabetes, although the term has not been formally established. It is important to distinguish between Alzheimer’s being referred to as Type 3 Diabetes and the already recognized and documented Type 3c Diabetes, which has a distinctly different pathology. Type 3c Diabetes develops when the pancreas experiences damage, such as from chronic pancreatitis or cystic fibrosis. Individuals with type 3c diabetes often also have a deficiency of pancreatic enzymes that are crucial for digestion. Type 3c diabetes is manageable with oral diabetes medications, and/or insulin.
I examine the causes, symptoms and modifiable lifestyle behaviours that can prevent Alzheimer’s disease. If these modifications are accepted and implemented by an individual with Alzheimer’s, they can mitigate the symptoms.
It may not be surprising to learn that the lifestyle changes required for Alzheimer’s prevention and reversal are the same as those required to Prevent and Reverse Type 2 Diabetes Naturally.
Researchers now understand the processes by which Alzheimer’s manifests in the brain. Several new, unique treatments are being investigated and prepared for trial. Additionally, the repurposing of existing cancer drugs as a treatment for Alzheimer’s is already underway.
